INVENTIVA (EPA:IVA) | Finanzwire

PRESS RELEASE

published on 10/14/2024 at 19:45, 1 year 6 months ago

Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants
Inventiva announces the availability of a prospectus for financing through the issuance of shares and warrants. The AMF approved the prospectus on October 14, 2024

Warrants Shares Financing Prospectus Inventiva
BRIEF

published on 08/30/2024 at 11:04, 1 year 8 months ago

UBS Group AG Crosses Threshold in INVENTIVA Capital

AMF Threshold Crossing Transfer Of Shares Inventiva UBS Group AG
BRIEF

published on 07/31/2024 at 22:05, 1 year 9 months ago

Inventiva Reports Preliminary 2024 First-Half Financial Information

Financial Results Revenue Inventiva H1 2024 R&D Expenses
PRESS RELEASE

published on 07/31/2024 at 22:00, 1 year 9 months ago

Inventiva Reports Preliminary 2024 First-Half Financial Information¹
Inventiva reports preliminary 2024 first-half financial information, including cash position, expenses, and funding concerns. No revenues recorded in H1 2024. Company remains focused on clinical trials and upcoming milestones

Financial Information Cash Position Clinical Trials Inventiva Funding Concerns
BRIEF

published on 07/25/2024 at 22:05, 1 year 9 months ago

Inventiva Secures Patent in Japan for Lanifibranor

Intellectual Property Japan Market Lanifibranor MASH/NASH Patent Approval
PRESS RELEASE

published on 07/25/2024 at 22:00, 1 year 9 months ago

Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor
Inventiva secures a new patent in Japan for lanifibranor, enhancing IP protection for cirrhosis treatment, including MASH/NASH indication

Patent Japan Inventiva Lanifibranor Cirrhosis
BRIEF

published on 07/23/2024 at 10:56, 1 year 9 months ago

UBS Group exceeds the threshold of 5% of Inventiva's capital

Voting Rights Acquisition Of Shares Crossing Threshold Inventive UBS Group
BRIEF

published on 07/18/2024 at 08:35, 1 year 9 months ago

Inventiva announces the issuance of royalty certificates for an amount of 20.1 million euros

Biopharmaceutical Inventive Lanifibranor MASH/NASH Royalty Certificates
PRESS RELEASE

published on 07/18/2024 at 08:30, 1 year 9 months ago

Inventiva announces a €20.1 million issuance of royalty certificates
Inventiva announces a €20.1 million issuance of royalty certificates to fund lanifibranor development, extending cash runway. Key shareholders involved in the transaction

Strategic Options Inventiva Lanifibranor Royalty Certificates Cash Runway
BRIEF

published on 07/05/2024 at 22:05, 1 year 9 months ago

Inventiva: update on the NATiV3 clinical program and financial statement

Funding Clinical Test Inventive NASH Lanifibranor

Published on 05/01/2026 at 04:00, 1 hour 21 minutes ago

Jericho Energy Ventures Announces Short Delay in Filing of 2025 Annual Financial Statements
Published on 05/01/2026 at 03:25, 1 hour 56 minutes ago

McEwen Inc. and Golden Lake Exploration Inc. Announce Closing of Arrangement
Published on 05/01/2026 at 02:55, 2 hours 26 minutes ago

GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results
Published on 05/01/2026 at 01:00, 4 hours 21 minutes ago

PPX Mining Announces Grant of Stock Options, Restricted Share Units and Deferred Share Units
Published on 05/01/2026 at 00:45, 4 hours 36 minutes ago

Inventus Announces Closing of $2.5 Million Non-Brokered Flow-Through Financing

View all ACCESSWIRE

Published on 04/30/2026 at 23:39, 5 hours 42 minutes ago

Anemoi International Ltd: Final Results For Year Ended 31 December 2025
Published on 04/30/2026 at 22:35, 6 hours 45 minutes ago

Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
Published on 04/30/2026 at 22:04, 7 hours 16 minutes ago

Interim individual financial statements for the period ending on March 31, 2026 of Sirma Group Holding JSC
Published on 04/30/2026 at 19:00, 10 hours 20 minutes ago

DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA
Published on 04/30/2026 at 19:00, 10 hours 21 minutes ago

BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders

View all EQS

Published on 04/30/2026 at 20:00, 9 hours 20 minutes ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 10 hours 5 minutes ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 10 hours 21 minutes ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 11 hours 11 minutes ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 11 hours 20 minutes ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News